SCHEMBL31708098

SCHEMBL31708098

C#CCNC(=O)C(=O)c1c[nH]c2cccc(OC(C)=O)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ SLC22A6 Q4U2R8 1/20 0.42
▸ PTGS2 P35354 1/20 0.41
▸ NR4A2 P43354 1/20 0.41
▸ MTNR1A P48039 1/20 0.41
▸ MTNR1B P49286 1/20 0.41
▸ GABRP O00591 7/20 0.40
▸ GABRD O14764 7/20 0.40
▸ GABRA1 P14867 7/20 0.40
▸ GABRB1 P18505 7/20 0.40
▸ GABRG2 P18507 7/20 0.40
▸ GABRB3 P28472 7/20 0.40
▸ GABRA5 P31644 7/20 0.40
▸ GABRA3 P34903 7/20 0.40
▸ GABRA2 P47869 7/20 0.40
▸ GABRB2 P47870 7/20 0.40
▸ GABRA4 P48169 7/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30276861 0.88 ALOX5 (0.44) ALOX5MEN1MAPTKMT2ASLC22A6
SCHEMBL31708212 0.85 MAPT (0.44) ALOX5MEN1MAPTKMT2ASLC22A6
SCHEMBL31708107 0.84 ALOX5 (0.41) ALOX5MEN1MAPTKMT2ASLC22A6
SCHEMBL31708134 0.84 SLC22A6 (0.47) ALOX5MEN1MAPTKMT2ASLC22A6
SCHEMBL31708138 0.81 SLC22A6 (0.44) ALOX5SLC22A6NR4A2MTNR1AMTNR1B
SCHEMBL30712078 0.80 SLC22A6 (0.50) SLC22A6PTGS2NR4A2MTNR1AMTNR1B
SCHEMBL31708071 0.79 RAB9A (0.52) MAPTSLC22A6NR4A2MTNR1AMTNR1B
SCHEMBL20898149 0.79 SLC22A6 (0.49) SLC22A6PTGS2NR4A2MTNR1AMTNR1B
SCHEMBL29504147 0.79 SLC22A6 (0.49) SLC22A6PTGS2NR4A2MTNR1AMTNR1B
SCHEMBL25792506 0.78 SLC22A6 (0.58) MEN1MAPTKMT2ASLC22A6PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4635492-A2 TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS Gilgamesh Pharmaceuticals, Inc. (US) 2025-10-22 — — EP disclosed
Send feedback